1. Review mechanisms of cardiotoxicity associated with pharmacologic therapies in patients with malignancies.
2. Describe measures that can be used to prevent and monitor treatment-related toxicities.
06/28/2018 - 8:00am to 9:00am CDT
NorthShore - Evanston
Evanston, IL 60201
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Hannah DeLuna, PharmD